1. Home
  2. NTRA vs RF Comparison

NTRA vs RF Comparison

Compare NTRA & RF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$197.88

Market Cap

29.2B

Sector

Health Care

ML Signal

HOLD

Logo Regions Financial Corporation

RF

Regions Financial Corporation

HOLD

Current Price

$26.79

Market Cap

24.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
RF
Founded
2003
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
29.2B
24.1B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
RF
Price
$197.88
$26.79
Analyst Decision
Strong Buy
Hold
Analyst Count
15
16
Target Price
$259.07
$29.44
AVG Volume (30 Days)
1.4M
9.4M
Earning Date
05-07-2026
04-17-2026
Dividend Yield
N/A
3.78%
EPS Growth
0.65
N/A
EPS
N/A
N/A
Revenue
$210,939,000.00
N/A
Revenue This Year
$18.08
$14.98
Revenue Next Year
$19.65
$3.82
P/E Ratio
N/A
$13.07
Revenue Growth
N/A
N/A
52 Week Low
$131.81
$20.79
52 Week High
$256.36
$31.53

Technical Indicators

Market Signals
Indicator
NTRA
RF
Relative Strength Index (RSI) 46.96 42.68
Support Level $187.27 $26.53
Resistance Level $204.34 $27.31
Average True Range (ATR) 10.36 0.59
MACD -1.12 -0.21
Stochastic Oscillator 28.02 13.79

Price Performance

Historical Comparison
NTRA
RF

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About RF Regions Financial Corporation

Regions Financial is one of the midsized regional banks in the US, with around $160 billion in total assets as of Sept. 30, 2025. Headquartered in Birmingham, Alabama, Regions Financial has a footprint mostly in the US southeast. The bank provides a diversified set of financial services in retail banking, commercial banking, card and treasury management, wealth management, and capital markets.

Share on Social Networks: